Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 195

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer

Open access
Jin, Huan, Ying, Xiaoling, Que, Biao, Wang, Xiaoxue, Chao, Yinghui, Zhang, Haiqing, Yuan, Zusen, Qi, Defeng, Lin, Shuibin, Min, Wang, Yang, Mei, Ji, Weidong · 2019 · EBioMedicine

Abstract

Background Accumulating evidence has revealed the critical roles of N 6 -methyladenosine (m 6 A) modification of mRNA in various cancers. However, the biological function and regulation of m 6 A in bladder cancer (BC) are not yet fully understood. Methods We performed cell phenotype analysis and established in vivo mouse xenograft models to assess the effects of m 6 A-modified ITGA6 on BC growth and progression. Methylated RNA immunoprecipitation (MeRIP), RNA immunoprecipitation and luciferase reporter and mutagenesis assays were used to define the mechanism of m 6 A-modified ITGA6. Immunohistochemical analysis was performed to assess the correlation between METTL3 and ITGA6 expression in bladder cancer patients. Findings We show that the m 6 A writer METTL3 and eraser ALKBH5 altered cell adhesion by regulating ITGA6 expression in bladder cancer cells. Moreover, upregulation of ITGA6 is correlated with the increase in METTL3 expression in human BC tissues, and higher expression of ITGA6 in patients indicates a lower survival rate. Mechanistically, m 6 A is highly enriched within the ITGA6 transcripts, and increased m 6 A methylations of the ITGA6 mRNA 3'UTR promotes the translation of ITGA6 mRNA via binding of the m 6 A readers YTHDF1 and YTHDF3. Inhibition of ITGA6 results in decreased growth and progression of bladder cancer cells in vitro and in vivo . Furthermore, overexpression of ITGA6 in METTL3-depleted cells partially restores the BC adhesion, migration and invasion phenotypes. Interpretation Our results demonstrate an oncogenic role of m 6 A-modified ITGA6 and show its regulatory mechanisms in BC development and progression, thus identifying a potential therapeutic target for BC. Fund This work was supported by National Natural Science Foundation of China (81772699, 81472999).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2019.07.068

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 195

Metadata

Authors
Jin, H., Ying, X., Que, B., Wang, X., Chao, Y., Zhang, H., Yuan, Z., Qi, D., Lin, S., Min, W., Yang, M., & Ji, W.
Venue
EBioMedicine
Publisher
Elsevier BV
Published
2019-09
Volume
47
Pages
195-207
ISSN
2352-3964 (ISSN-L)
OpenAlex
W2968332102
Cited by
195
References
12
FWCI
7.66
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer. https://app.cochat.ai/papers/10.1016/j.ebiom.2019.07.068
The paper
Jin, H., Ying, X., Que, B., Wang, X., Chao, Y., Zhang, H., Yuan, Z., Qi, D., Lin, S., Min, W., Yang, M., & Ji, W. (2019). N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer. EBioMedicine. https://doi.org/10.1016/j.ebiom.2019.07.068

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.